BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 18617056)

  • 21. Contribution of cytogenetics and FISH in the diagnosis of meningiomas. A study of 189 tumors.
    Zattara-Cannoni H; Gambarelli D; Dufour H; Figarella D; Vollot F; Grisoli F; Vagner-Capodano AM
    Ann Genet; 1998; 41(3):164-75. PubMed ID: 9833072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SNP-based arrays complement classic cytogenetics in the detection of chromosomal aberrations in Wilms' tumor.
    Zin R; Pham K; Ashleigh M; Ravine D; Waring P; Charles A
    Cancer Genet; 2012 Mar; 205(3):80-93. PubMed ID: 22469507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-nucleotide polymorphism array karyotyping in clinical practice: where, when, and how?
    Sato-Otsubo A; Sanada M; Ogawa S
    Semin Oncol; 2012 Feb; 39(1):13-25. PubMed ID: 22289488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single nucleotide polymorphism array-based karyotyping shows sequential genomic changes from monosomy to copy-neutral loss of heterozygosity of chromosome 7 and 20q deletion within a balanced translocation t(14;20) in AML.
    Huh J; Mun YC; Seong CM; Chung WS
    Cancer Genet; 2011 Dec; 204(12):682-6. PubMed ID: 22285021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histopathological and cytogenetic findings in benign, atypical and anaplastic human meningiomas: a study of 60 tumors.
    Cerdá-Nicolás M; López-Ginés C; Pérez-Bacete M; Barcia-Salorio JL; Llombart-Bosch A
    Clin Neuropathol; 2000; 19(6):259-67. PubMed ID: 11128617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletion of chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas.
    Müller P; Henn W; Niedermayer I; Ketter R; Feiden W; Steudel WI; Zang KD; Steilen-Gimbel H
    Clin Cancer Res; 1999 Nov; 5(11):3569-77. PubMed ID: 10589773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytogenetic, FISH and array-CGH characterization of a complex chromosomal rearrangement carried by a mentally and language impaired patient.
    Ballarati L; Recalcati MP; Bedeschi MF; Lalatta F; Valtorta C; Bellini M; Finelli P; Larizza L; Giardino D
    Eur J Med Genet; 2009; 52(4):218-23. PubMed ID: 19236961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inactivation patterns of NF2 and DAL-1/4.1B (EPB41L3) in sporadic meningioma.
    Nunes F; Shen Y; Niida Y; Beauchamp R; Stemmer-Rachamimov AO; Ramesh V; Gusella J; MacCollin M
    Cancer Genet Cytogenet; 2005 Oct; 162(2):135-9. PubMed ID: 16213361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A translocation t(6;7)(p11-p12;q22) associated with autism and mental retardation: localization and identification of candidate genes at the breakpoints.
    Vincent JB; Choufani S; Horike S; Stachowiak B; Li M; Dill FJ; Marshall C; Hrynchak M; Pewsey E; Ukadike KC; Friedman JM; Srivastava AK; Scherer SW
    Psychiatr Genet; 2008 Jun; 18(3):101-9. PubMed ID: 18496206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cytogenetic relationship between primary and recurrent meningiomas points to the need for new treatment strategies in cases at high risk of relapse.
    Espinosa AB; Tabernero MD; Maíllo A; Sayagués JM; Ciudad J; Merino M; Alguero MC; Lubombo AM; Sousa P; Santos-Briz A; Orfao A
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):772-80. PubMed ID: 16467088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11.
    Flotho C; Steinemann D; Mullighan CG; Neale G; Mayer K; Kratz CP; Schlegelberger B; Downing JR; Niemeyer CM
    Oncogene; 2007 Aug; 26(39):5816-21. PubMed ID: 17353900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of complex chromosome aberrations in a recurrent meningioma combining standard cytogenetic and array comparative genomic hybridization techniques.
    Woo KS; Sung KS; Kim KU; Shaffer LG; Han JY
    Cancer Genet Cytogenet; 2008 Jan; 180(1):56-9. PubMed ID: 18068535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive analysis of loss of heterozygosity events in glioblastoma using the 100K SNP mapping arrays and comparison with copy number abnormalities defined by BAC array comparative genomic hybridization.
    Lo KC; Bailey D; Burkhardt T; Gardina P; Turpaz Y; Cowell JK
    Genes Chromosomes Cancer; 2008 Mar; 47(3):221-37. PubMed ID: 18050302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel chromosomal aberrations in a recurrent malignant meningioma.
    Pelz AF; Klawunde P; Skalej M; Wieacker P; Kirches E; Schneider T; Mawrin C
    Cancer Genet Cytogenet; 2007 Apr; 174(1):48-53. PubMed ID: 17350466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of chromosome 1p deletion using FISH on meningioma touch imprints suggest a region outside chromosome 22 as important in tumor recurrence.
    Tamiolakis D; Papadopoulos N; Lambropoulou M; Kotini A; Simopoulos C
    Minerva Med; 2003 Feb; 94(1):51-6. PubMed ID: 12719702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular cytogenetic analysis of breast cancer: a combined multicolor fluorescence in situ hybridization and G-banding study of uncultured tumor cells.
    Ferti AD; Stamouli MJ; Panani AD; Raptis SA; Young BD
    Cancer Genet Cytogenet; 2004 Feb; 149(1):28-37. PubMed ID: 15104280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical utilization of high-resolution single nucleotide polymorphism based oligonucleotide arrays in diagnostic studies of pediatric patients with solid tumors.
    Dougherty MJ; Tooke LS; Sullivan LM; Hakonarson H; Wainwright LM; Biegel JA
    Cancer Genet; 2012; 205(1-2):42-54. PubMed ID: 22429597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular cytogenetic characterization of human papillomavirus16-transformed foreskin keratinocyte cell line 16-MT.
    McGhee EM; Cotter PD; Weier JF; Berline JW; Turner MA; Gormley M; Palefsky JM
    Cancer Genet Cytogenet; 2006 Jul; 168(1):36-43. PubMed ID: 16772119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide DNA-mapping of CD34+ cells from patients with myelodysplastic syndrome using 500K SNP arrays identifies significant regions of deletion and uniparental disomy.
    Nowak D; Nolte F; Mossner M; Nowak V; Baldus CD; Hopfer O; Noll S; Thiel E; Wagner F; Hofmann WK
    Exp Hematol; 2009 Feb; 37(2):215-224. PubMed ID: 19135900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of cryptic chromosomal lesions including acquired segmental uniparental disomy in advanced and low-risk myelodysplastic syndromes.
    Gondek LP; Haddad AS; O'Keefe CL; Tiu R; Wlodarski MW; Sekeres MA; Theil KS; Maciejewski JP
    Exp Hematol; 2007 Nov; 35(11):1728-38. PubMed ID: 17920760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.